Shari Annes | IR |
Rachel King | President, CEO & Director |
Brian Hahn | SVP, CFO & Secretary |
Helen Thackray | SVP, Clinical Development & Chief Medical Officer |
Subhalaxmi Nambi | Cowen and Company |
Peter Lawson | SunTrust Robinson Humphrey |
Danielle Brill | Piper Jaffray Companies |
Stephen Willey | Stifel, Nicolaus & Company |
Biren Amin | Jefferies |
Edward White | H.C. Wainwright & Co. |
Good morning, and thank you all for joining GlycoMimetics Second Quarter 2019 Conference Call. [Operator Instructions].
I would now like to turn the call over to Shari Annes of the Investor Relations Group at GlycoMimetics. Please go ahead.
Good morning.